By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Wellcome Genome Campus

Hinxton  Cambridge  CB10 1DR  United Kingdom
Phone: 44-1223-499-965 Fax: n/a


Congenica is a UK company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and regional genetic testing laboratories. We’ve translated this research into the gold standard clinical genomic analytics platform, Sapientia®, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide actionable interpretation of genetic disease for patients.




CEO: Thomas Weaver

COO: Nick Lench


Please click here for Congenica's products.

Key Statistics

Ownership: Private

Web Site: Congenica


Company News
Congenica’s Sapientia Selected By Coimbra Paediatric Hospital For Portugal’s In2genome Genetic Disease Diagnosis Project 9/6/2017 10:37:48 AM
China's BGI And Healthlink Invest And Make Deal With UK's Congenica 4/28/2017 8:26:19 AM
Congenica Completes Series B Financing Round With Investments From China-Based BGI Healthlink And Future Planet 4/27/2017 5:48:01 AM
Congenica And Edico Genome Partner To Speed Analysis From 'DNA To Diagnosis' For Inherited Diseases 4/20/2017 9:21:55 AM
Congenica Raises £8M ($10M) In Series B Financing Round To Drive International Expansion Of Its Genome Analysis Business 3/1/2017 9:52:34 AM
Congenica Release: Integrating Whole Genome Analysis Into Clinical Practice 12/2/2016 10:09:47 AM
Elucigene Partners With Congenica On New NGS Cystic Fibrosis Kit 12/1/2016 8:39:34 AM
Congenica Release: New Facility Placing Cambridge UK At Forefront Of Genomics Revolution 11/22/2016 8:05:44 AM
Congenica Release: Sapientia Detecting Clinically Relevant Variants In 35% Of First Diagnostic Reports Delivered To UK 100,000 Genomes Project 10/21/2016 10:16:47 AM